OUR HISTORY

Founded in 2014, ACE Research is a specialized African CRO offering early and late-phase full-service clinical research services for biopharmaceutical companies, Universities, and government agencies.

Our pharma-trained team of experts is dedicated to helping clients achieve clinical research success across five platforms—vaccines, drugs, diagnostics, devices, and observational and ethnographic studies.

2014

October

KISUMU, KENYA

Established as ClinicalRM Africa in the Republic of Kenya

Opened headquarters in Kisumu, Kenya.

  • October 2014 – Launched Ebola convalescent trials in Liberia.

    March 2015 – Opened HQ office in Kisumu, Kenya.

    April 2015 – Appointed Advisory Board

  • August 2026 – Launched vaccine studies in Kenya, Uganda, Tanzania, Rwanda, Mozambique, Nigeria, Burkina Faso, Ivory Coast

    November 2026 – Rebranded to ACE Research

  • October 2017- Exhibited at ASTMH, Atlanta Georgia

2018

October

ACE Research

Rebranding

Incorporated ACE Research in Sierra Leone, West Africa

Rolled out vaccine and treatment trials in Sierra Leone, Guinea, Liberia and East and central Africa

October 2019 – Incorporated ACE Research in Democratic Republic of Congo (DRC)

Kenya
Sierra Leone
The DRC

2021

March

ACE Research, USA

March 2021 – Incorporated in USA

ACE Research is a renowned clinical research organization that has achieved tremendous organic growth in the USA market. With almost a decade of experience, we are committed to providing excellent and client-centric solutions, which has earned us the trust of pharmaceutical and biotech partners worldwide. Our success is a testament to our expert team, diverse portfolio of trials, and ability to adapt to industry changes. ACE Research CRO continues to lead the way in shaping the future of clinical research in Sub-Saharan Africa and beyond.